Steven M Albelda

9PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 13, 2026
Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-cell Engineering against Pancreatic Tumors.

Khuloud Bajbouj, Zebin Xiao, Leslie Todd

|Jan 13, 2026
Taking "Multiple Shots on Goal" with an Armed Invariant NK Cell Approach.

Steven M Albelda

|May 07, 2025
PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural Mesothelioma.

Gwendolyn M Cramer, Richard W Davis, Emmanouil Papasavvas

|Oct 31, 2023
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn.

Steven M Albelda

Pageof 2